Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Caesar J. Belbel currently holds 207,434 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Caesar J. Belbel has been a net seller of ZIOP stock. They have purchased $0 and sold $2.6M worth of shares.
Caesar J. Belbel's most recent insider trade was on Dec 31, 2017, when they sold 21,667 shares at $4.14 per share.
Caesar J. Belbel serves as Executive at ZIOPHARM ONCOLOGY INC (ZIOP). They have executed 77 insider transactions totaling $2.6M over their tenure at the company.
Caesar J. Belbel holds the position of Executive at ZIOPHARM ONCOLOGY INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Caesar J. Belbel has shown a selling trading pattern, with $0 in total purchases and $2.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Caesar J. Belbel was on Nov 19, 2015, when they sold $2.0M worth of ZIOP shares. This transaction involved 153,333 shares at $12.84 per share.
Caesar J. Belbel currently owns 207,434 shares of ZIOPHARM ONCOLOGY INC (ZIOP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Caesar J. Belbel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Caesar J. Belbel has 77 Form 4 filings on record as an insider at ZIOPHARM ONCOLOGY INC.
Set alerts for Caesar J. Belbel and 40,000+ other insiders.